subject: CHEBI:28748

object_name: Locally Advanced Malignant Peripheral Nerve Sheath Tumor


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Unresectable Malignant Peripheral Nerve Sheath Tumor

tested_intervention: unsure


subject: CHEBI:28748

object_name: Unresectable Liposarcoma


subject: CHEBI:28748

object_name: pleomorphic rhabdomyosarcoma


subject: CHEBI:28748

object_name: adult pleomorphic rhabdomyosarcoma


subject: CHEBI:230905

subject_name: Ribociclib

object_name: Advanced Soft Tissue Sarcoma


subject: CHEBI:230905

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:230905

object_name: Metastatic Soft Tissue Sarcoma


subject: CHEBI:230905

object_name: Unresectable Soft Tissue Sarcoma


subject: CHEBI:230905

object_name: Stage IV Soft Tissue Sarcoma AJCC v7


subject: CHEBI:230905

object_name: Stage III Soft Tissue Sarcoma AJCC v7


subject: CHEBI:230905

object_name: Liposarcoma metastatic


subject: CHEBI:230905

object_name: Metastatic fibrosarcoma


subject: CHEBI:230905

object_name: Metastatic angiosarcoma


subject: CHEBI:230905

object_name: Metastatic synovial sarcoma


subject: CHEBI:230905

object_name: Locally Advanced Liposarcoma


subject: CHEBI:230905

object_name: Metastatic myxofibrosarcoma


subject: CHEBI:230905

object_name: Epithelioid sarcoma metastatic


subject: CHEBI:230905

object_name: Locally Advanced Angiosarcoma


subject: CHEBI:230905

object_name: Locally Advanced Leiomyosarcoma


subject: CHEBI:230905

object_name: Malignant fibrous histiocytoma metastatic


subject: CHEBI:230905

object_name: Locally Advanced Myxofibrosarcoma


subject: CHEBI:230905

object_name: Locally Advanced Undifferentiated Pleomorphic Sarcoma


subject: CHEBI:230905

object_name: undifferentiated embryonal sarcoma of the liver


subject: CHEBI:230905

object_name: undifferentiated (embryonal) sarcoma


subject: CHEBI:230905

object_name: Unresectable Synovial Sarcoma


subject: CHEBI:230905

object_name: myxofibrosarcoma


subject: CHEBI:230905

object_name: Metastatic Malignant Peripheral Nerve Sheath Tumor


subject: CHEBI:230905

object_name: Locally Advanced Malignant Peripheral Nerve Sheath Tumor


subject: CHEBI:230905

object_name: Unresectable Undifferentiated Pleomorphic Sarcoma


subject: CHEBI:230905

object_name: Unresectable Malignant Peripheral Nerve Sheath Tumor


subject: CHEBI:230905

object_name: Unresectable Liposarcoma


subject: CHEBI:230905

object_name: Unresectable Leiomyosarcoma


subject: CHEBI:230905

object_name: childhood pleomorphic rhabdomyosarcoma


subject: CHEBI:230905

object_name: pleomorphic rhabdomyosarcoma


subject: CHEBI:230905

object_name: adult pleomorphic rhabdomyosarcoma


subject: UMLS:C5773278

object_name: kidney failure

tested_intervention: yes


subject: PUBCHEM.COMPOUND:2269

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:2269

object_name: heart disorder


subject: PUBCHEM.COMPOUND:2269

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:2269

object_name: myocardial infarction


subject: PUBCHEM.COMPOUND:2269

object_name: Myocardial Infarction, CTCAE


subject: PUBCHEM.COMPOUND:2269

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: UMLS:C5555561

subject_name: Anti-LAG-3 Monoclonal Antibody LBL-007

object_name: non-small cell lung carcinoma


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Radiation enteritis of intestine


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Intraoperative Hemorrhage


subject: UMLS:C0358321

subject_name: Immune Globulin (Human)

object_name: autism


subject: UMLS:C0358321

object_name: pervasive developmental disorder


subject: UMLS:C0358321

object_name: digestive system disorder


subject: UMLS:C0358321

object_name: Digestive System Signs and Symptoms


subject: UMLS:C3537193

subject_name: Human Immunoglobulin [EPC]


subject: UMLS:C3537193


subject: UMLS:C3537193


subject: UMLS:C3537193


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: kidney disorder


subject: PUBCHEM.COMPOUND:3249

object_name: impaired renal function disease


subject: PUBCHEM.COMPOUND:3249

object_name: Paresis


subject: PUBCHEM.COMPOUND:3249

object_name: Muscle weakness


subject: PUBCHEM.COMPOUND:3249

object_name: Bone fracture


subject: UMLS:C3714696

subject_name: Ergocalciferol Drug Product


subject: UMLS:C3714696


subject: UMLS:C3714696


subject: UMLS:C3714696


subject: UMLS:C3714696


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27565

subject_name: Aminosalicylic acid

object_name: Crohn disease


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: intrahepatic cholangiocarcinoma


subject: UMLS:C1948073


subject: UMLS:C2716558

subject_name: GAP 134

object_name: Arrhythmia


subject: CHEBI:9434

subject_name: Telmisartan

object_name: obstructive sleep apnea syndrome


subject: CHEBI:42724

subject_name: levamfetamine


subject: CHEBI:42724


subject: CHEBI:42724

object_name: autism spectrum disorder


subject: CHEBI:35338

subject_name: amphetamines


subject: CHEBI:35338


subject: CHEBI:35338


subject: CHEBI:132233

subject_name: Amphetamine


subject: CHEBI:132233


subject: CHEBI:132233


subject: UMLS:C0219461

subject_name: regramostim

object_name: Varicose Ulcer


subject: MESH:D020136

subject_name: Hydrogel


subject: MESH:D011054

subject_name: Poliovirus Vaccine, Inactivated

object_name: Diarrhea rotavirus


subject: MESH:D011054

object_name: tropical sprue


subject: MESH:D011054

object_name: Vaccine virus shedding


subject: UMLS:C5241183

subject_name: Vaccine product containing only inactivated whole Human poliovirus antigen (medicinal product)


subject: UMLS:C5241183


subject: UMLS:C5241183


subject: UMLS:C2364569

subject_name: rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain


subject: UMLS:C2364569


subject: CHEBI:9927

subject_name: Valsartan

object_name: stroke disorder


subject: CHEBI:9927

object_name: cerebrovascular disorder


subject: CHEBI:9927

object_name: Stroke (heart beat)


subject: CHEBI:9927

object_name: Stroke, CTCAE


subject: CHEBI:9927

object_name: Mental deterioration


subject: CHEBI:9927

object_name: Cognitive impairment


subject: CHEBI:2668

subject_name: Amlodipine


subject: CHEBI:2668


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: CHEBI:3139

subject_name: bleomycin

object_name: cancer


subject: CHEBI:3139

object_name: neoplasm


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: Prediabetes


subject: CHEBI:53760

object_name: Diabetes


subject: CHEBI:53760

object_name: diabetes mellitus


subject: CHEBI:53760

object_name: glucose intolerance


subject: CHEBI:53760

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:31932

subject_name: olmesartan

object_name: type 2 diabetes mellitus


subject: CHEBI:31932

object_name: kidney disorder


subject: CHEBI:31932

object_name: impaired renal function disease


subject: PUBCHEM.COMPOUND:56998

object_name: leprosy


subject: UMLS:C4722543

subject_name: Toll-like Receptor 4 Agonist GLA-SE


subject: UMLS:C4722544

subject_name: Glucopyranosyl Lipid Adjuvant-Stable Emulsion


subject: CHEBI:177770

subject_name: Ganetespib

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:177770

object_name: stage IV pancreatic cancer


subject: CHEBI:177770

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:177770

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:177770

object_name: pancreatic adenocarcinoma


subject: PR:000003719

subject_name: disintegrin and metalloproteinase domain-containing protein 23

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C1707048

subject_name: broccoli sprout extract

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UMLS:C1707048

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UMLS:C1707048

object_name: Stage IB Breast Cancer AJCC v7


subject: UMLS:C1707048

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UMLS:C1707048

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UMLS:C1707048

object_name: Stage IA Breast Cancer AJCC v7


subject: UMLS:C1707048

object_name: stage IA breast cancer


subject: UMLS:C1707048

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C1707048

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C1707048

object_name: Stage IIA Breast Carcinoma


subject: UMLS:C1707048

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C1707048

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C1707048

object_name: Stage IIB Breast Carcinoma


subject: UMLS:C1707048

object_name: malignant neoplasm of breast stage IIb


subject: UMLS:C1707048

object_name: breast lobular carcinoma


subject: UMLS:C1707048

object_name: breast ductal adenocarcinoma


subject: UMLS:C1707048

object_name: invasive breast carcinoma


subject: UMLS:C1707048

object_name: ductal breast carcinoma in situ


subject: UMLS:C1707048

object_name: Estrogen Receptor Positive


subject: UMLS:C1707048

object_name: Estrogen Receptor Negative


subject: UMLS:C1707048

object_name: Postmenopausal


subject: UNII:KB7A32K6Z6

object_name: Disseminated Malignant Neoplasm


subject: UNII:KB7A32K6Z6

object_name: Embolism, Tumor


subject: UNII:KB7A32K6Z6

object_name: Neoplasm Metastasis


subject: UNII:KB7A32K6Z6

object_name: metastatic colorectal cancer


subject: UNII:KB7A32K6Z6

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:KB7A32K6Z6

object_name: Carcinoma breast stage IV


subject: UNII:KB7A32K6Z6

object_name: Metastatic malignant neoplasm to pancreas


subject: UNII:KB7A32K6Z6

object_name: Metastatic urothelial carcinoma


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: gingival recession


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Dysesthesia


subject: CHEBI:144094

subject_name: bicalutamide

object_name: castration-resistant prostate carcinoma


subject: CHEBI:144094

object_name: metastatic neoplasm


subject: CHEBI:144094


subject: CHEBI:144094


subject: CHEBI:144094

object_name: Metastatic Lesion


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699

object_name: prostate neoplasm


subject: CHEBI:79699


subject: CHEBI:79699


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Adhesive Capsulitis


subject: UMLS:C0445115

object_name: frozen shoulder


subject: UMLS:C0445115

object_name: bursitis


subject: UMLS:C0745378

subject_name: intranasal drug

object_name: no feeling or sensation of skin


subject: UMLS:C0745378

object_name: Sensory Loss


subject: HMDB:HMDB0032337

subject_name: Hydroxypropyl cellulose

object_name: Acute Ischemic Stroke


subject: HMDB:HMDB0032337

object_name: Ischemic stroke


subject: CHEBI:9168

subject_name: Sirolimus

object_name: congenital vascular malformation


subject: CHEBI:9168

object_name: vascular anomaly


subject: CHEBI:93522

object_name: Kaposi Sarcoma


subject: CHEBI:93522

object_name: HIV infection


subject: GTOPDB:12361

subject_name: sabatolimab

object_name: chronic myelomonocytic leukemia


subject: UNII:3L7R886Y06

subject_name: SABATOLIMAB


subject: GTOPDB:10140

subject_name: spartalizumab


subject: GTOPDB:10140

object_name: Myelodysplasia


subject: UNII:QOG25L6Z8Z


subject: UNII:QOG25L6Z8Z


subject: GTOPDB:7394

subject_name: gevokizumab

object_name: acne


subject: CHEMBL.COMPOUND:CHEMBL1743026

subject_name: GEVOKIZUMAB


subject: UMLS:C3179523


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: adverse effect of cardiovascular medications


subject: CHEBI:8707

subject_name: Quetiapine

object_name: bipolar II disorder


subject: UMLS:C3714217

object_name: pancreatic neoplasm


subject: UMLS:C3714217

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3714217

object_name: malignant pancreatic neoplasm


subject: CHEBI:52717

subject_name: Bortezomib

object_name: squamous cell carcinoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: substance-induced psychosis


subject: CHEBI:4466

object_name: drug psychosis


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UMLS:C0388976

subject_name: Ecteinascidin 743

object_name: breast disorder


subject: UMLS:C0388976

object_name: breast neoplasm


subject: UMLS:C0388976

object_name: cancer


subject: UMLS:C0388976

object_name: skin disorder


subject: UMLS:C0388976

object_name: neoplasm


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:49865963


subject: UniProtKB:Q99RL2

subject_name: SBI_STAAN Immunoglobulin-binding protein Sbi (sprot)

object_name: mucositis


subject: UniProtKB:Q8NV09

subject_name: SBI_STAAW Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:Q5HDD7

subject_name: SBI_STAAC Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:Q6G6Q3

subject_name: SBI_STAAS Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:A6QJQ7

subject_name: SBI_STAAE Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:Q6GE15

subject_name: SBI_STAAR Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:A6U4E8

subject_name: SBI_STAA2 Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:Q2FE79

subject_name: SBI_STAA3 Immunoglobulin-binding protein Sbi (sprot)


subject: UMLS:C3896610

subject_name: Serum-derived Bovine Immunoglobulin Protein Isolate


subject: UniProtKB:A5IVJ8

subject_name: SBI_STAA9 Immunoglobulin-binding protein Sbi (sprot)


subject: PR:000024853

subject_name: immunoglobulin-binding protein Sbi


subject: UniProtKB:A8YYG7

subject_name: SBI_STAAT Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:Q2YVZ4

subject_name: SBI_STAAB Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:A7X659

subject_name: SBI_STAA1 Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:Q931F4

subject_name: SBI_STAAM Immunoglobulin-binding protein Sbi (sprot)


subject: UMLS:C5853389

object_name: pulmonary sarcoidosis


subject: CHEBI:8024

subject_name: Perindopril

object_name: metastatic colorectal cancer


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: liver carcinoma


subject: UNII:2285XW22DR

object_name: advanced adult primary liver cancer


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Neonatal Late-Onset Sepsis


subject: CHEBI:146207

subject_name: palytoxin


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: plasma cell myeloma


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Plaque, Atherosclerotic


subject: CHEBI:34967

subject_name: Rimonabant

object_name: eating disorder


subject: UMLS:C1174273


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: psoriasis


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:84040

object_name: Hypercholesterolemia


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: head and neck squamous cell carcinoma


subject: CHEBI:6824

subject_name: Methenamine

object_name: Dysuria


subject: CHEBI:6824

object_name: Dysuria, CTCAE


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: PUBCHEM.COMPOUND:368860

subject_name: Becatecarin

object_name: Small cell lung cancer extensive stage


subject: PUBCHEM.COMPOUND:368860

object_name: Small cell lung cancer limited stage


subject: PUBCHEM.COMPOUND:368860

object_name: Small cell lung cancer recurrent


subject: CHEBI:9168

subject_name: Sirolimus

object_name: pemphigus


subject: CHEBI:45716

subject_name: Vorinostat

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:45716

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:45716

object_name: primary cutaneous lymphoma


subject: CHEBI:45716

object_name: Cutaneous lymphoma


subject: UNII:4N9P6CC1DX

subject_name: Echinacea

object_name: ulcerative colitis


subject: UNII:4N9P6CC1DX

object_name: inflammatory bowel disease 1


subject: CHEBI:83160

subject_name: Echinacea extract


subject: CHEBI:83160


subject: UMLS:C5139959

object_name: kidney failure


subject: UNII:LMQ24G57E9

subject_name: Daridorexant


subject: CHEBI:233453

object_name: acute apical periodontitis


subject: CHEBI:35854

subject_name: Valaciclovir


subject: UMLS:C5554939

subject_name: Becotatug

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:3183

subject_name: Brompheniramine

object_name: Allergy


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: pancreatic neoplasm


subject: CHEBI:17061

object_name: exocrine pancreatic carcinoma


subject: CHEBI:17061

object_name: malignant pancreatic neoplasm


subject: CHEBI:17061

object_name: Advanced Pancreatic Adenocarcinoma


subject: CHEBI:17061

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:30011

subject_name: L-glutamine residue


subject: CHEBI:30011


subject: CHEBI:30011


subject: CHEBI:30011


subject: CHEBI:30011


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C4722508

subject_name: Polycap

object_name: arteriosclerosis disorder


subject: UMLS:C4722508

object_name: atherosclerosis


subject: UMLS:C4722508

object_name: Immune Tolerance


subject: UMLS:C4722508

object_name: Drug Tolerance


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: Application site pigmentation changes


subject: CHEBI:63925

subject_name: PhXa 85


subject: CHEBI:188986

subject_name: idose


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:10127

subject_name: Zonisamide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:10127

object_name: obesity


subject: CHEBI:10127

object_name: Obesity, CTCAE


subject: CHEBI:33699

subject_name: messenger RNA

object_name: influenza


subject: UMLS:C0018909

subject_name: Hemagglutinin


subject: CHEBI:33349

subject_name: dubnium atom


subject: CHEBI:33357

subject_name: hassium atom


subject: CHEBI:133630

subject_name: His-Ala


subject: UniProtKB:P03456

subject_name: HEMA_I68A3 Hemagglutinin (sprot)


subject: UniProtKB:P03446

subject_name: HEMA_I76A2 Hemagglutinin (sprot)


subject: UniProtKB:A3DRP0

subject_name: HEMA_I96A2 Hemagglutinin (sprot)


subject: UniProtKB:A4K143

subject_name: HEMA_I54A2 Hemagglutinin (sprot)


subject: UniProtKB:B4URD6

subject_name: HEMA_I06A0 Hemagglutinin (sprot)


subject: UniProtKB:Q0A448

subject_name: hemagglutinin (Influenza A virus (strain A/Duck/Germany/1949 H10N7))


subject: UMLS:C4285347

subject_name: Ha Antibody


subject: UniProtKB:Q9WCD8

subject_name: HEMA_I61A1 Hemagglutinin (sprot)


subject: UniProtKB:P03453

subject_name: HEMA_I77AB Hemagglutinin (sprot)


subject: UniProtKB:A4U7A6

subject_name: HEMA_I51A0 Hemagglutinin (sprot)


subject: UniProtKB:P13103

subject_name: HEMA_I77AF Hemagglutinin (sprot)


subject: UniProtKB:P26136

subject_name: HEMA_I82A1 Hemagglutinin (sprot)


subject: UniProtKB:P07976

subject_name: HEMA_I83A5 Hemagglutinin (sprot)


subject: UniProtKB:A4GBX7

subject_name: HEMA_I77AA Hemagglutinin (sprot)


subject: UniProtKB:P19698

subject_name: HEMA_I79A7 Hemagglutinin (sprot)


subject: UniProtKB:Q6LEJ4

subject_name: HEMA_I80A2 Hemagglutinin (sprot)


subject: UniProtKB:P03457

subject_name: HEMA_I66A1 Hemagglutinin (sprot)


subject: UniProtKB:A4GCL9

subject_name: HEMA_I35A3 Hemagglutinin (sprot)


subject: UniProtKB:Q9WFX3

subject_name: HEMA_I18A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U6V2

subject_name: HEMA_I45A0 Hemagglutinin (sprot)


subject: UniProtKB:Q07FI5

subject_name: HEMA_I96A3 Hemagglutinin (sprot)


subject: UniProtKB:P03454

subject_name: HEMA_I33A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCK8

subject_name: HEMA_I43A0 Hemagglutinin (sprot)


subject: UniProtKB:P03448

subject_name: HEMA_I72A5 Hemagglutinin (sprot)


subject: UniProtKB:A4GCI6

subject_name: HEMA_I36A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCJ7

subject_name: HEMA_I80AA Hemagglutinin (sprot)


subject: UniProtKB:P04661

subject_name: HEMA_I56A2 Hemagglutinin (sprot)


subject: UniProtKB:Q0HD60

subject_name: HEMA_I40A0 Hemagglutinin (sprot)


subject: UniProtKB:P26139

subject_name: HEMA_I77A4 Hemagglutinin (sprot)


subject: UniProtKB:A4GCH5

subject_name: HEMA_I83A1 Hemagglutinin (sprot)


subject: CHEBI:27504

subject_name: Mitomycin

object_name: head and neck squamous cell carcinoma


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UMLS:C5854553

subject_name: Anti-CD123/CD16A Bispecific Antibody AFM28

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5854553

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:368860

subject_name: Becatecarin

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:368860

object_name: De Novo Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:368860

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:368860

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:368860

object_name: Secondary Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:368860

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: PUBCHEM.COMPOUND:368860

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:368860

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:368860

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:368860

object_name: chronic myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:368860

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:368860

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:368860

object_name: recurrent adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:368860

object_name: Previously Treated Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:368860

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:368860

object_name: myelodysplastic syndrome with excess blasts


subject: PUBCHEM.COMPOUND:368860

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:47458

subject_name: Saracatinib

object_name: Small cell lung cancer extensive stage


subject: CHEBI:47458

object_name: Small cell lung cancer recurrent


subject: CHEBI:47458

object_name: Malignant pleural effusion


subject: CHEBI:47458

object_name: Secondary malignant neoplasm of lung


subject: CHEMBL.COMPOUND:CHEMBL1743016

subject_name: FARLETUZUMAB

object_name: fallopian tube carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743016

object_name: fallopian tube cancer


subject: CHEMBL.COMPOUND:CHEMBL1743016

object_name: peritoneal neoplasm


subject: UMLS:C1831845


subject: UMLS:C1831845


subject: UMLS:C1831845


subject: CHEBI:63632

subject_name: Topotecan

object_name: Stomach cancer


subject: CHEBI:63632

object_name: gastric cancer


subject: CHEBI:63632

object_name: Neck Carcinoma


subject: CHEBI:63632

object_name: head and neck neoplasm


subject: CHEBI:63632

object_name: head and neck cancer


subject: CHEBI:63632

object_name: pancreatic neoplasm


subject: CHEBI:63632

object_name: exocrine pancreatic carcinoma


subject: CHEBI:63632

object_name: malignant pancreatic neoplasm


subject: CHEBI:64312

subject_name: Memantine

object_name: prostate carcinoma


subject: CHEBI:64312

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:21982135

object_name: Emergence Delirium


subject: CHEBI:73038

subject_name: Parecoxib


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: respiratory failure


subject: CHEBI:16347

object_name: Respiratory Failure, CTCAE


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: cervical squamous cell carcinoma


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UNII:564ROC9U09

object_name: hepatitis C


subject: UNII:564ROC9U09

object_name: Adult Liver Carcinoma


subject: CHEBI:91400

subject_name: Afatinib

object_name: Unresectable Solid Neoplasm


subject: CHEBI:91400

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:91400

object_name: cholangiocarcinoma


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:Y6BX7BL23K


subject: UNII:Y6BX7BL23K


subject: UMLS:C3886636

object_name: Tinnitus


subject: UMLS:C3886636

object_name: Tinnitus, CTCAE 5.0


subject: UMLS:C3886636

object_name: Tinnitus, CTCAE 3.0


subject: UNII:XG6DG6A1UN

subject_name: VONAFEXOR

object_name: Alport syndrome


subject: DRUGBANK:DB18782

subject_name: Vonafexor


subject: UMLS:C4528200

subject_name: Glioma Lysate Vaccine GBM6-AD

object_name: glioma


subject: UMLS:C4528200

object_name: malignant glioma


subject: UMLS:C4528200

object_name: diffuse astrocytoma


subject: UMLS:C4528200

object_name: astrocytoma


subject: UMLS:C4528200

object_name: glioma susceptibility 1


subject: UMLS:C4528200

object_name: adult oligodendroglioma


subject: UMLS:C4528200

object_name: oligodendroglioma


subject: UMLS:C4528200

object_name: childhood oligodendroglioma


subject: UMLS:C4528200

object_name: oligoastrocytoma


subject: CHEBI:131724

subject_name: iclaprim

object_name: Skin structures and soft tissue infections


subject: CHEBI:131751

subject_name: Iclaprim


subject: UMLS:C5214487

subject_name: Antiplatelet

object_name: Heart Disease Risk Factors


subject: UMLS:C5214487

object_name: hypertension


subject: UMLS:C5214487

object_name: Hypertension, CTCAE


subject: UMLS:C5203527

subject_name: Methotrexate Liquid Injection

object_name: rhegmatogenous retinal detachment


subject: UMLS:C5203527

object_name: CAPN5-related vitreoretinopathy


subject: UMLS:C5203527

object_name: proliferative vitreoretinopathy


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: alcohol abuse


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: plantar wart


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:2453

subject_name: Acyclovir


subject: UMLS:C5556548

subject_name: CD122-selective IL-2/Anti-CD25 Antibody-like Fusion Protein ANV419

object_name: lung cancer


subject: UMLS:C5556548

object_name: lung neoplasm


subject: UMLS:C5556548

object_name: lung carcinoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: adult disease


subject: DRUGBANK:DB17575

subject_name: Utidelone

object_name: triple-negative breast carcinoma


subject: CHEBI:136007

subject_name: methylnaltrexone

object_name: Well adult


subject: CHEBI:6741

subject_name: Meloxicam

object_name: Inflammation


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Prostatitis category III (National Institute of Health classification)


subject: CHEBI:9398

subject_name: Tamsulosin


subject: CHEBI:7726

subject_name: octreotide

object_name: Seroma following procedure


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:28364

subject_name: Icosapent


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: CHEBI:91899

object_name: Acute exacerbation of bronchiectasis


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:38940

subject_name: Sunitinib

object_name: childhood kidney cell carcinoma


subject: CHEBI:201491

subject_name: Amoxicillin Clavulanate

object_name: tuberculosis


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: CHEBI:43968

subject_name: Meropenem


subject: UNII:ZLW14X2D30

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:ZLW14X2D30

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:ZLW14X2D30

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:ZLW14X2D30

object_name: myeloproliferative neoplasm


subject: UNII:ZLW14X2D30

object_name: bone marrow neoplasm


subject: UNII:ZLW14X2D30

object_name: myelodysplastic syndrome with excess blasts


subject: UNII:ZLW14X2D30

object_name: acute lymphoblastic leukemia


subject: UNII:ZLW14X2D30

object_name: acute myeloid leukemia by FAB classification


subject: UNII:ZLW14X2D30

object_name: acute myeloid leukemia


subject: UNII:ZLW14X2D30

object_name: marginal zone lymphoma


subject: UNII:ZLW14X2D30

object_name: MALT lymphoma


subject: UNII:ZLW14X2D30

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:ZLW14X2D30

object_name: mantle cell lymphoma


subject: UNII:ZLW14X2D30

object_name: lymphoplasmacytic lymphoma


subject: UNII:ZLW14X2D30

object_name: Waldenstrom macroglobulinemia


subject: UNII:ZLW14X2D30

object_name: lymphoblastic lymphoma


subject: UNII:ZLW14X2D30

object_name: Adult Lymphoblastic Lymphoma


subject: UNII:ZLW14X2D30

object_name: Childhood Lymphoblastic Lymphoma


subject: UNII:ZLW14X2D30

object_name: follicular lymphoma


subject: UNII:ZLW14X2D30

object_name: Burkitt lymphoma


subject: UMLS:C0108779

subject_name: CD3 Antigens

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C0108779

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C0108779

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C0108779

object_name: myeloproliferative neoplasm


subject: UMLS:C0108779

object_name: bone marrow neoplasm


subject: UMLS:C0108779

object_name: myelodysplastic syndrome with excess blasts


subject: UMLS:C0108779

object_name: acute lymphoblastic leukemia


subject: UMLS:C0108779

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0108779

object_name: acute myeloid leukemia


subject: UMLS:C0108779

object_name: marginal zone lymphoma


subject: UMLS:C0108779

object_name: MALT lymphoma


subject: UMLS:C0108779

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C0108779

object_name: mantle cell lymphoma


subject: UMLS:C0108779

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C0108779

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C0108779

object_name: lymphoblastic lymphoma


subject: UMLS:C0108779

object_name: Adult Lymphoblastic Lymphoma


subject: UMLS:C0108779

object_name: Childhood Lymphoblastic Lymphoma


subject: UMLS:C0108779

object_name: follicular lymphoma


subject: UMLS:C0108779

object_name: Burkitt lymphoma


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin

object_name: Sepsis


subject: UMLS:C0392939

object_name: Sepsis, CTCAE


subject: UMLS:C1134588

object_name: amyloidosis


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: Nail psoriasis


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Labor Pain


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:44151801

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:44151801

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:44151801

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:44151801

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:44151801

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:44151801

object_name: leukemia


subject: PUBCHEM.COMPOUND:44151801

object_name: childhood leukemia


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: UMLS:C0724557

subject_name: CLEANSER

object_name: acne


subject: UMLS:C4727551

subject_name: Colorectal Cancer Peptide Vaccine PolyPEPI1018

object_name: Metastatic Colorectal Carcinoma


subject: UMLS:C4727551

object_name: Metastatic Colorectal Adenocarcinoma


subject: UMLS:C4727551

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: UMLS:C4727551

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UMLS:C4727551

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: UMLS:C4727551

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: UMLS:C4727551

object_name: Adenocarcinoma of colon metastatic


subject: UMLS:C4727551

object_name: Metastatic rectal adenocarcinoma


subject: UMLS:C4727551

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: UMLS:C4727551

object_name: Metastatic Microsatellite Stable Colon Carcinoma


subject: UMLS:C4727551

object_name: Microsatellite Stable Rectal Carcinoma


subject: CHEBI:75179

subject_name: Trifluridine


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: cognitive disorder


subject: CHEBI:135686

subject_name: Alvimopan

object_name: Gastrointestinal dysfunction


subject: UMLS:C5706440

subject_name: Anti-PD-1/Anti-TIM-3 Bispecific Antibody LB1410

object_name: Childhood Solid Neoplasm


subject: UMLS:C5706440

object_name: Adult Solid Neoplasm


subject: UMLS:C5706440

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:359323

subject_name: PENTAMIDINE ISETHIONATE

object_name: Cicatrix, Hypertrophic


subject: CHEBI:45081

subject_name: Pentamidine


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: Squamous cell carcinoma of head and neck recurrent


subject: GTOPDB:11376

object_name: Second Primary Squamous Cell Carcinoma of the Head and Neck


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: MESH:C526287

object_name: hereditary von Willebrand disease


subject: MESH:C526287

object_name: von Willebrand disease (hereditary or acquired)


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Osteoporotic Fractures


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:2767

object_name: myeloproliferative neoplasm


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672

object_name: plasma cell myeloma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib


subject: UNII:Y6BX7BL23K


subject: UNII:Y6BX7BL23K

object_name: Stomach cancer


subject: UNII:Y6BX7BL23K

object_name: gastric cancer


subject: UNII:Y6BX7BL23K


subject: UNII:Y6BX7BL23K

object_name: lung cancer


subject: UNII:Y6BX7BL23K

object_name: lung neoplasm


subject: UNII:Y6BX7BL23K

object_name: lung carcinoma


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab


subject: UNII:2Y3T5IF01Z


subject: UNII:2Y3T5IF01Z

object_name: cholangiocarcinoma


subject: UNII:2Y3T5IF01Z


subject: UNII:2Y3T5IF01Z


subject: UNII:2Y3T5IF01Z


subject: UNII:2Y3T5IF01Z


subject: UNII:2Y3T5IF01Z


subject: UNII:2Y3T5IF01Z


subject: UNII:2Y3T5IF01Z

object_name: Childhood Solid Neoplasm


subject: UNII:2Y3T5IF01Z

object_name: Adult Solid Neoplasm


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Cerebral Venous Thrombosis Related to COVID-19


subject: CHEBI:6413

subject_name: Letrozole

object_name: micropapillary serous carcinoma


subject: CHEBI:230905

subject_name: Ribociclib


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: MESH:C520255

object_name: Metastatic malignant neoplasm to peritoneum


subject: MESH:C520255

object_name: Metastatic gastric adenocarcinoma


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1134558

subject_name: Chinese Herbs

object_name: Childhood Breast Carcinoma


subject: UMLS:C1134558

object_name: breast carcinoma


subject: UMLS:C1134558

object_name: breast cancer


subject: UMLS:C1134558

object_name: Metastatic malignant neoplasm to bone


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:11635624

object_name: coronary atherosclerosis


subject: CHEBI:70839

subject_name: Dasatinib

object_name: brain disorder


subject: CHEBI:70839

object_name: CNS disorder


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C4289046

subject_name: Gallium Ga 68-NOTA-BBN(7-14)-RGD


subject: UMLS:C4289046


subject: UMLS:C4289046


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Clear-cell metastatic renal cell carcinoma


subject: CHEBI:72317

object_name: Advanced Clear Cell Renal Cell Carcinoma


subject: UMLS:C3640822

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C3640822

object_name: chronic myelomonocytic leukemia


subject: UMLS:C3640822

object_name: Previously Treated Myelodysplastic Syndrome


subject: UMLS:C3640822

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: acute coronary syndrome


subject: GTOPDB:9640

subject_name: rontalizumab

object_name: EXCESS LMW-DNA


subject: CHEMBL.COMPOUND:CHEMBL1743066

subject_name: RONTALIZUMAB


subject: PUBCHEM.COMPOUND:135618605

subject_name: poly If

object_name: Menopause present (finding)


subject: PUBCHEM.COMPOUND:135618605

object_name: Menopause


subject: CHEBI:37931

subject_name: Phenothiazine


subject: CHEBI:37931


subject: CHEBI:33853

subject_name: phenols


subject: CHEBI:33853


subject: UMLS:C4528574

subject_name: PTPN11 inhibitor TNO155

object_name: Advanced cancer


subject: UMLS:C4528574

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4528574

object_name: Embolism, Tumor


subject: UMLS:C4528574

object_name: Neoplasm Metastasis


subject: UMLS:C4528574

object_name: cancer


subject: CHEBI:9637

subject_name: Torasemide

object_name: ADHF


subject: CHEBI:3213

subject_name: Bumetanide


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE

object_name: failure; transplant, kidney


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:64019

subject_name: Nebivolol


subject: CHEBI:32139

object_name: Sunstroke


subject: CHEBI:32139

object_name: Heat Stroke


subject: CHEBI:32139

object_name: Acute kidney injury due to hypovolemia


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Overweight


subject: CHEBI:52717

subject_name: Bortezomib

object_name: glioma


subject: CHEBI:52717

object_name: malignant glioma


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: bronchopulmonary dysplasia


subject: CHEBI:35176

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:35176

object_name: perinatal necrotizing enterocolitis


subject: CHEBI:35176

object_name: necrotizing enterocolitis


subject: CHEBI:35176

object_name: retinopathy of prematurity


subject: CHEBI:35176

object_name: exudative vitreoretinopathy 1


subject: CHEBI:35176

object_name: Retinopathy of Prematurity, AE


subject: CHEBI:35176

object_name: Neonatal Early-Onset Sepsis


subject: CHEBI:35176

object_name: fetal growth restriction


subject: CHEBI:35176

object_name: Periventricular haemorrhage neonatal


subject: CHEBI:28364

subject_name: Icosapent

object_name: Severe Sepsis


subject: CHEBI:28364

object_name: Sepsis


subject: CHEBI:28364

object_name: Sepsis, CTCAE


subject: CHEBI:28364

object_name: septic shock


subject: CHEBI:28661

subject_name: Gamolenic acid


subject: CHEBI:28661


subject: CHEBI:28661


subject: CHEBI:28661


subject: CHEBI:47898

subject_name: Epirubicin

object_name: neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743064

subject_name: ROBATUMUMAB


subject: UMLS:C3467798


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UNII:52CMI0WC3Y

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:52CMI0WC3Y

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UNII:52CMI0WC3Y

object_name: Squamous cell carcinoma of the oral cavity stage III


subject: UNII:52CMI0WC3Y

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Squamous cell carcinoma of the oral cavity stage IV


subject: UNII:52CMI0WC3Y

object_name: Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:75722

subject_name: Tramadol

object_name: birth (history)


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Surgical procedure finding


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: platelet aggregation, spontaneous


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:92043599

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:92043599

object_name: Hodgkin Disease


subject: CHEBI:31721

subject_name: Irsogladine maleate

object_name: Peptic Ulcer


subject: CHEBI:93307

subject_name: Irsogladine


subject: UMLS:C0091573

subject_name: irsogladine maleate


subject: CHEBI:31759

subject_name: Lafutidine


subject: CHEBI:2611

subject_name: Alprazolam

object_name: Adverse reaction to COVID-19 vaccine


subject: CHEBI:3756

subject_name: Clonazepam


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:63618

subject_name: Pravastatin


subject: UNII:WB8FT61183


subject: UMLS:C4033631

subject_name: sacubitril / valsartan


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEBI:41423

subject_name: Celecoxib

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:S173RED00L

subject_name: Otamixaban

object_name: coronary artery disorder


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:41774

object_name: pulmonary hypertension


subject: CHEBI:41774

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:41774

object_name: pulmonary arterial hypertension


subject: CHEBI:41774

object_name: hypertension


subject: CHEBI:41774

object_name: Hypertension, CTCAE


subject: CHEBI:41774

object_name: primary pulmonary hypertension


subject: CHEBI:41774

object_name: heritable pulmonary arterial hypertension


subject: CHEBI:41774

object_name: Poisoning by, adverse effect of and underdosing of other hormone antagonists


subject: CHEBI:41774

object_name: lung disorder


subject: CHEBI:58097

object_name: Dysesthesia


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:18248

subject_name: Iron

object_name: colorectal carcinoma


subject: CHEBI:18248

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C1166521


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: UMLS:C3714701


subject: PUBCHEM.COMPOUND:13889162

subject_name: Isomaltoside


subject: PUBCHEM.COMPOUND:13889162


subject: UMLS:C1572570

subject_name: PEANUT preparation

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:53395955

subject_name: Natrecor

object_name: Exacerbation of congestive heart failure


subject: UMLS:C1170421


subject: CHEBI:229213

subject_name: Elacestrant

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:229213

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:229213

object_name: Breast cancer stage III


subject: CHEBI:229213

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:229213

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:229213

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:229213

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:229213

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:229213

object_name: malignant neoplasm of breast stage IIb


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Hormone receptor positive tumor


subject: UMLS:C3641122


subject: UMLS:C4053581

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C4053581

object_name: lung neoplasm


subject: CHEBI:135207

subject_name: Clofedanol

object_name: stroke of basilar artery


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:184023

subject_name: Argininosuccinic acid


subject: PR:000004321

subject_name: arylsulfatase A


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]


subject: CHEBI:151315

subject_name: Heparin


subject: PUBCHEM.COMPOUND:135210935

subject_name: luvometinib

object_name: low grade glioma


subject: UMLS:C5966108

subject_name: Luvometinib


subject: PUBCHEM.COMPOUND:4454

subject_name: Neomycin sulfate

object_name: infectious disease


subject: PUBCHEM.COMPOUND:4454

object_name: Anastomotic Leak


subject: UNII:057Y626693

subject_name: NEOMYCIN SULFATE


subject: UNII:057Y626693


subject: CHEBI:31635

subject_name: neomycin sulfate


subject: CHEBI:31635


subject: CHEBI:7507

subject_name: Framycetin


subject: CHEBI:7507


subject: CHEBI:8764

subject_name: Mycophenolate mofetil

object_name: Disorder of transplanted kidney


subject: CHEBI:8764

object_name: IMMUNE SUPPRESSION


subject: UMLS:C2958914

subject_name: INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT

object_name: Skin Wrinkling


subject: UMLS:C4743433

subject_name: onabotulinum toxin A


subject: CHEBI:94534

subject_name: olanzapine

object_name: female reproductive organ cancer


subject: CHEBI:3921

subject_name: Cromakalim

object_name: Cerebral Blood Flow


subject: CHEBI:6436

subject_name: Levcromakalim


subject: UMLS:C0244960


subject: CHEBI:135945

subject_name: Pixantrone

object_name: diffuse large B-cell lymphoma


subject: CHEBI:135945

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:135945

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:135945

object_name: Lymphoma, Large-Cell, Follicular


subject: UMLS:C3710982

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: cardiotoxicity


subject: UMLS:C5433403

subject_name: Forxiga


subject: CHEBI:94759

subject_name: Triclabendazole

object_name: fascioliasis


subject: CHEBI:73510

subject_name: Glu-Thr

object_name: Helicobacter pylori infection


subject: PR:000010374

subject_name: UNC93-like protein MFSD11


subject: CHEBI:3207

subject_name: Budesonide

object_name: Acute asthma


subject: CHEBI:2549

subject_name: Albuterol


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: DRUGBANK:DB11010

subject_name: Cod, unspecified

object_name: Inflammation


subject: DRUGBANK:DB11010

object_name: arteriosclerosis disorder


subject: DRUGBANK:DB11010

object_name: atherosclerosis


subject: DRUGBANK:DB11010

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB11010

object_name: obesity


subject: DRUGBANK:DB11010

object_name: Obesity, CTCAE


subject: PR:000029730

subject_name: small nuclear ribonucleoprotein-associated proteins B and B'


subject: PR:000029730


subject: PR:000029730


subject: PR:000029730


subject: PR:000029730


subject: PR:000029730


subject: UMLS:C3488428

subject_name: cod, unspecified preparation


subject: UMLS:C3488428


subject: UMLS:C3488428


subject: UMLS:C3488428


subject: UMLS:C3488428


subject: UMLS:C3488428


subject: UMLS:C0056632


subject: UMLS:C0056632


subject: UMLS:C0056632


subject: UMLS:C0056632


subject: UMLS:C0056632


subject: UMLS:C0056632


subject: UMLS:C2362561

subject_name: Gluten


subject: UMLS:C2362561


subject: UMLS:C2362561


subject: UMLS:C2362561


subject: UMLS:C2362561


subject: UMLS:C2362561


subject: UMLS:C2827346

subject_name: wheat gluten extract


subject: UMLS:C2827346


subject: UMLS:C2827346


subject: UMLS:C2827346


subject: UMLS:C2827346


subject: UMLS:C2827346


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Coronary artery calcification


subject: CHEBI:46245

object_name: coronary stenosis


subject: CHEBI:3001

subject_name: beclomethasone

object_name: COPD exacerbation


subject: PUBCHEM.COMPOUND:9919001

subject_name: FORMOTEROL FUMARATE


subject: CHEBI:74705

object_name: Crohn disease


subject: PR:000009425


subject: PR:000016318


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: interstitial lung disease 1


subject: CHEBI:28939

object_name: interstitial lung disease 2


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Adult Acute Basophilic Leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Acute Eosinophilic Leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:4911

subject_name: Etoposide

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: CHEBI:4911

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: CHEBI:4911

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:4911


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE

object_name: Adult Acute Myeloid Leukemia in Remission


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate

object_name: prostate carcinoma


subject: CHEBI:32296

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:391960

subject_name: Darifenacin

object_name: Urinary incontinence


subject: CHEBI:391960

object_name: Urinary Incontinence, CTCAE 5.0


subject: UNII:HU43305R7O

object_name: cancer


subject: UNII:HU43305R7O

object_name: neoplasm


subject: UNII:2C4Y86R2AX


subject: UNII:2C4Y86R2AX


subject: CHEBI:88249

subject_name: Mirdametinib

object_name: plasma cell myeloma


subject: UMLS:C3817338

subject_name: Cysview

object_name: colorectal cancer


subject: UMLS:C3817338

object_name: colorectal carcinoma


subject: UMLS:C3817338

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:6T4O391P5Y

subject_name: Vactosertib

object_name: myeloproliferative neoplasm


subject: UNII:6T4O391P5Y

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:3374

subject_name: Capsaicin

object_name: cannabinoid hyperemesis syndrome


subject: UNII:L65E7T81M5

subject_name: DULANERMIN

object_name: metastatic colorectal cancer


subject: UMLS:C1522480

subject_name: AMG 951


subject: UMLS:C5783284

subject_name: ROPivacaine 0.75% injectable solution

object_name: Post-Operative Pain


subject: CHEBI:55379

subject_name: camphorsulfonic acid

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:55379

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:55379

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:55379

object_name: acute myeloid leukemia


subject: CHEBI:55379


subject: CHEBI:55379

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:55379

object_name: acute lymphoblastic leukemia


subject: CHEBI:55379

object_name: non-Hodgkin lymphoma


subject: CHEBI:55379

object_name: Hodgkin Disease


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: PR:000007170


subject: PR:000007170


subject: PR:000007170


subject: PR:000007170

object_name: plasma cell myeloma


subject: PR:000007170


subject: PR:000007170


subject: PR:000007170


subject: PR:000007170


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine


subject: PUBCHEM.COMPOUND:4739


subject: PUBCHEM.COMPOUND:4739


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY

object_name: type 2 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL2108391

object_name: Insulin resistance


subject: MESH:C086631

subject_name: mineral trioxide aggregate

object_name: Tooth Injuries


subject: UNII:0VMV8Z3972

object_name: secondary progressive multiple sclerosis


subject: UNII:0VMV8Z3972

object_name: primary progressive multiple sclerosis


subject: UNII:0VMV8Z3972

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C5447430

subject_name: Fluorine F 18 DPA-714


subject: UMLS:C5447430


subject: UMLS:C5447430


subject: CHEBI:49140


subject: CHEBI:49140


subject: CHEBI:49140


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:16382

subject_name: Iodide

object_name: non-small cell lung carcinoma


subject: UMLS:C3537218

subject_name: Neuraminidase Inhibitor [EPC]


subject: CHEBI:8988

object_name: Locally Advanced Cervical Carcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: influenza


subject: UNII:IZY9ZSI6FI

subject_name: ZILOVERTAMAB VEDOTIN

object_name: Burkitt lymphoma


subject: UNII:IZY9ZSI6FI

object_name: Childhood Burkitt Lymphoma


subject: UNII:IZY9ZSI6FI

object_name: Adult Burkitt Lymphoma


subject: UNII:IZY9ZSI6FI

object_name: Ewing sarcoma


subject: UNII:IZY9ZSI6FI

object_name: Childhood Neuroblastoma


subject: UNII:IZY9ZSI6FI

object_name: neuroblastoma


subject: UNII:IZY9ZSI6FI

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UNII:IZY9ZSI6FI

object_name: B-cell acute lymphoblastic leukemia


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: CHEBI:8774

subject_name: Ramipril

object_name: Normal blood pressure


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: renal carcinoma


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C0021735

object_name: kidney cancer


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:70789204

object_name: stage IV pancreatic cancer


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: Pancreatic carcinoma recurrent


subject: PUBCHEM.COMPOUND:70789204

object_name: pancreatic acinar cell carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: pancreatic ductal adenocarcinoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: UMLS:C5854568

subject_name: Oncolytic HSV-1 R130

object_name: digestive system cancer


subject: UMLS:C5854568


subject: UMLS:C5854568

object_name: kidney neoplasm


subject: UMLS:C5854568


subject: UMLS:C5854568

object_name: brain cancer


subject: UMLS:C5854568

object_name: brain neoplasm


subject: UMLS:C5854568

object_name: melanoma


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Relapse multiple myeloma


subject: CHEBI:6888

object_name: Plasma cell myeloma recurrent


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Plasma cell myeloma refractory


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:229764


subject: PUBCHEM.COMPOUND:23594367

subject_name: Boceprevir

object_name: Chronic hepatitis C genotype 1


subject: CHEBI:149601

subject_name: Bempedoic acid

object_name: cardiovascular disorder


subject: CHEBI:149601

object_name: Non-ST Elevated Myocardial Infarction


subject: CHEBI:149601

object_name: Non-ST Elevation Myocardial Infarction


subject: CHEBI:149601

object_name: ST-elevation myocardial infarction


subject: CHEBI:149601

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:49040

subject_name: Ezetimibe


subject: CHEBI:49040


subject: CHEBI:49040


subject: CHEBI:49040


subject: MESH:C000714913

object_name: Hot Flashes, CTCAE


subject: MESH:C000714913

object_name: Hot flashes


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Eye Pain, CTCAE 5.0


subject: UMLS:C0013227

object_name: Eye Pain, CTCAE 3.0


subject: UMLS:C0013227

object_name: Ocular pain


subject: UMLS:C0013227

object_name: eye inflammation


subject: UMLS:C0013227

object_name: endophthalmitis


subject: UMLS:C0013227

object_name: Ocular surface disease


subject: UMLS:C0013227

object_name: Ocular Surface Disease, CTCAE


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: hypertension


subject: PUBCHEM.COMPOUND:521372

object_name: Hypertension, CTCAE


subject: CHEBI:30745

subject_name: Phenylacetic acid

object_name: hepatic encephalopathy


subject: UMLS:C1612488

subject_name: Xibrom

object_name: cystoid macular edema


subject: PUBCHEM.COMPOUND:13633150

subject_name: Methyl prednisolonate

object_name: relapsing-remitting multiple sclerosis


subject: MESH:C000720529

subject_name: VXA-CoV2-1.1-S vaccine


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: leukoplakia


subject: UNII:DPT0O3T46P

object_name: Erythroleukoplakia


subject: UNII:DPT0O3T46P

object_name: Verrucous oral leukoplakia


subject: UNII:DPT0O3T46P

object_name: Proliferative verrucous oral leukoplakia


subject: PR:000001345

subject_name: endoglin

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: PR:000017525

subject_name: Y-box-binding protein 1


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:64816


subject: CHEBI:64816

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:17026

subject_name: Progesterone

object_name: placental abruption


subject: CHEBI:17026

object_name: progesterone resistance


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: UNII:D652ZWF066

subject_name: sodium zirconium cyclosilicate

object_name: secondary hyperparathyroidism


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: prostate cancer


subject: CHEBI:2567

object_name: prostate neoplasm


subject: CHEBI:49603

subject_name: Lapatinib

object_name: gastroesophageal cancer


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:9907

subject_name: ursodiol

object_name: sclerosing cholangitis


subject: CHEBI:9907

object_name: primary sclerosing cholangitis


subject: CHEMBL.COMPOUND:CHEMBL461806

subject_name: ELTROMBOPAG OLAMINE

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: recurrent adult acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Adult Pure Erythroid Leukemia


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: adult acute monocytic leukemia


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Adult Acute Monoblastic Leukemia


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Adult Acute Basophilic Leukemia


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: acute megakaryoblastic leukemia in adult


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Adult Erythroleukemia


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Adult Acute Eosinophilic Leukemia


subject: UMLS:C1880492

subject_name: eltrombopag olamine

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UMLS:C1880492

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UMLS:C1880492

object_name: adult acute myeloid leukemia with del(5q)


subject: UMLS:C1880492

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UMLS:C1880492

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C1880492

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UMLS:C1880492

object_name: Adult Acute Myelomonocytic Leukemia


subject: UMLS:C1880492

object_name: Adult Pure Erythroid Leukemia


subject: UMLS:C1880492

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: UMLS:C1880492

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: UMLS:C1880492

object_name: adult acute monocytic leukemia


subject: UMLS:C1880492

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: UMLS:C1880492

object_name: Adult Acute Monoblastic Leukemia


subject: UMLS:C1880492

object_name: Adult Acute Basophilic Leukemia


subject: UMLS:C1880492

object_name: acute megakaryoblastic leukemia in adult


subject: UMLS:C1880492

object_name: Adult Erythroleukemia


subject: UMLS:C1880492

object_name: Adult Acute Eosinophilic Leukemia


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: bone cancer


subject: UNII:GKF8S4C432

object_name: bone neoplasm


subject: GTOPDB:9132

subject_name: vanucizumab

object_name: neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3545259

subject_name: VANUCIZUMAB


subject: UMLS:C3896777


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Nasal Polyp


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Nonsquamous nonsmall cell neoplasm of lung


subject: PUBCHEM.COMPOUND:21874242

subject_name: Vinflunine

object_name: Bladder transitional cell carcinoma stage IV


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:93775

subject_name: Amethopterin

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:93775

object_name: vitiligo


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UMLS:C3896794

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C3896794

object_name: clear cell renal carcinoma


subject: UMLS:C3896794

object_name: renal cell adenocarcinoma


subject: UMLS:C3896794

object_name: renal cell carcinoma


subject: CHEBI:8764

subject_name: Mycophenolate mofetil

object_name: CREST syndrome


subject: CHEBI:8764

object_name: Sclerodactyly


subject: UMLS:C4279317

subject_name: Dietressa

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C4279317

object_name: obesity


subject: UMLS:C4279317

object_name: Obesity, CTCAE


subject: UNII:E6BTT8VA5Z

subject_name: Filorexant

object_name: migraine


subject: UNII:E6BTT8VA5Z

object_name: migraine with or without aura, susceptibility to, 1


subject: UNII:E6BTT8VA5Z

object_name: Headache


subject: UNII:E6BTT8VA5Z

object_name: Headache, CTCAE


subject: CHEBI:233364

subject_name: Bryostatin

object_name: Childhood Breast Carcinoma


subject: CHEBI:233364

object_name: breast carcinoma


subject: CHEBI:233364

object_name: breast cancer


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: AA amyloidosis


subject: UMLS:C1512628

subject_name: Medicinal product acting as imaging agent (product)

object_name: plasma cell myeloma


subject: UMLS:C1512628

object_name: Plasma cell myeloma recurrent


subject: UMLS:C1512628


subject: UMLS:C5399731

subject_name: Imaging Agent [APC]


subject: UMLS:C5399731


subject: UMLS:C5399731


subject: UMLS:C0677518

subject_name: Magnesiocard

object_name: Metastatic non-small cell lung cancer


subject: UNII:DU3I0H5Z4H

subject_name: Magnesium levulinate


subject: UMLS:C0126775

subject_name: Magnesium diasporal


subject: CHEBI:45630

subject_name: Laevulinic Acid


subject: CHEBI:22660

subject_name: aspartic acid


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: Nail psoriasis


subject: UMLS:C1831775


subject: UMLS:C1831775


subject: UMLS:C1831775


subject: UMLS:C1831775

object_name: CNS disorder


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Failure to thrive in infant


subject: UNII:NQX9KB6PCL

object_name: Undergrowth


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: GTOPDB:12790

subject_name: crovalimab

object_name: sickle cell disease


subject: UNII:H9KH1GP3UU

subject_name: CROVALIMAB


subject: UMLS:C5418336


subject: CHEBI:10782

subject_name: Perilla alcohol

object_name: pancreatic neoplasm


subject: CHEBI:10782

object_name: exocrine pancreatic carcinoma


subject: CHEBI:10782

object_name: malignant pancreatic neoplasm


subject: CHEBI:145806

subject_name: (R)-(+)-perillyl alcohol


subject: CHEBI:145806


subject: CHEBI:145806


subject: CHEBI:15420

subject_name: perillyl alcohol


subject: CHEBI:15420


subject: CHEBI:15420


subject: PUBCHEM.COMPOUND:6918224

subject_name: QUETIAPINE FUMARATE

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:6918224

object_name: alcohol dependence


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: IDH2 gene mutation


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:145374

subject_name: Enasidenib

object_name: bilineal acute myeloid leukemia


subject: CHEBI:145374

object_name: acute biphenotypic leukemia


subject: CHEBI:145374

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:145374

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:145374

object_name: chronic myelomonocytic leukemia


subject: CHEMBL.COMPOUND:CHEMBL4650237

subject_name: ILTAMIOCEL

object_name: Bowel incontinence


subject: CHEMBL.COMPOUND:CHEMBL4650237

object_name: Fecal Incontinence, CTCAE


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: fibromyalgia


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:10125

subject_name: Zolpidem

object_name: Fusion of spine (disease)


subject: CHEBI:10125

object_name: Lumbar spine degeneration


subject: CHEBI:10125

object_name: Lumbar spondylosis


subject: CHEBI:10125

object_name: Post-Operative Pain


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Kinetic tremor


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:77543

subject_name: Ebselen


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:01KC87F8FE

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UNII:01KC87F8FE


subject: PR:000010011

subject_name: lysosomal-trafficking regulator


subject: PR:000010011


subject: PR:000003655


subject: PR:000003655


subject: CHEBI:51209

subject_name: Pseudoephedrine

object_name: Upper Respiratory Infections


subject: CHEBI:51209

object_name: respiratory tract infectious disorder


subject: CHEBI:15365

subject_name: Aspirin

object_name: Hypercholesterolemia


subject: UMLS:C0206492

subject_name: Antibodies, Bispecific

object_name: thyroid tumor


subject: CHEBI:71223

subject_name: Pralatrexate

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C2742830

subject_name: Ismigen

object_name: allergic asthma


subject: CHEBI:42567

subject_name: Fisetin

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:42567

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:42567

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C4046044

object_name: rheumatoid arthritis


subject: MESH:C000728624

object_name: mantle cell lymphoma


subject: UMLS:C4329438


subject: CHEBI:7773

subject_name: Ondansetron

object_name: pancreas disorder


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Stage I Hepatocellular Carcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage II Hepatocellular Carcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IB Hepatocellular Carcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IA Hepatocellular Carcinoma AJCC v8


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:3139

subject_name: bleomycin

object_name: Cutaneous warts


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Hypovolemic shock


subject: CHEBI:28918

object_name: septic shock


subject: CHEBI:194548

subject_name: Racepinephrine


subject: CHEBI:194548


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Chondrosarcoma metastatic


subject: CHEBI:71219

object_name: bone chondrosarcoma


subject: CHEBI:71219

object_name: chondrosarcoma


subject: UNII:AP4OF2M98B

subject_name: EMIXUSTAT HYDROCHLORIDE

object_name: proliferative diabetic retinopathy


subject: UMLS:C5419246

subject_name: Emixustat Hydrochloride


subject: UMLS:C3537249

subject_name: D Vitamin

object_name: pulmonary tuberculosis


subject: UMLS:C5205927

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C4733327

subject_name: anti-CD98 monoclonal antibody KHK2898

object_name: Solid Neoplasm


subject: UMLS:C1699394

subject_name: Hylenex

object_name: psoriasis


subject: UNII:96265TNH2R

subject_name: Gedatolisib

object_name: Malignant neoplasm of female breast


subject: UNII:4N9P6CC1DX

subject_name: Echinacea

object_name: common cold


subject: UMLS:C5445960

subject_name: Echinacea antigen


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Ischemic stroke


subject: CHEBI:18357

subject_name: Norepinephrine


subject: UMLS:C0729210

subject_name: Isovue

object_name: pulmonary embolism


subject: MESH:D003069

subject_name: Coffee

object_name: Overweight


subject: MESH:D003069

object_name: obesity


subject: CHEBI:8871

subject_name: Risperidone

object_name: substance-related disorder


subject: UMLS:C5555781

subject_name: Oncolytic Adenovirus AdAPT-001

object_name: malignant soft tissue neoplasm


subject: UMLS:C5555781

object_name: sarcoma


subject: UMLS:C5555781

object_name: Adult Solid Neoplasm


subject: UMLS:C5555781

object_name: bone chondrosarcoma


subject: UMLS:C5555781

object_name: chondrosarcoma


subject: UMLS:C5555781

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C5555781

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C5555781

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C5555781

object_name: soft tissue sarcoma


subject: UMLS:C5555781

object_name: neoplasm


subject: UMLS:C5555781

object_name: cancer


subject: CHEBI:42944

subject_name: Galantamine

object_name: psychosis


subject: CHEBI:42944

object_name: Psychotic disorder due to a general medical condition


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: UNII:S7V92P67HO


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Bladder cancer recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: anterior urethra cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Transitional cell cancer of the renal pelvis and ureter localised


subject: PUBCHEM.COMPOUND:2767

object_name: Regional Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Urethral Cancer


subject: CHEBI:91872

object_name: ureter cancer


subject: CHEBI:91872

object_name: ureter carcinoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: CHEBI:93775

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775

object_name: urethral carcinoma associated with invasive bladder cancer


subject: CHEBI:93775

object_name: Distal Urethral Carcinoma


subject: CHEBI:93775


subject: CHEBI:93775

object_name: posterior urethra cancer


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:134813

subject_name: Chlorobutanol

object_name: Oral Mucositis


subject: CHEBI:134813

object_name: stomatitis


subject: CHEBI:134813

object_name: oral mucositis


subject: CHEBI:94339

subject_name: Hexetidine


subject: CHEBI:94339


subject: CHEBI:94339


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:22976653

object_name: adult acute respiratory distress syndrome


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UNII:1RXS4UE564


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Schizophrenic psychoses


subject: UNII:32524GLF40

object_name: major depressive disorder


subject: UNII:Z5MR2Y1IJJ

subject_name: Enavogliflozin

object_name: tricuspid valve insufficiency


subject: UNII:Z5MR2Y1IJJ

object_name: Heart failure with normal ejection fraction


subject: PUBCHEM.COMPOUND:3367

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Pleural effusion


subject: CHEBI:119915

object_name: Pleural Effusion, CTCAE


subject: CHEBI:119915

object_name: x-ray of chest: pleural effusion


subject: CHEBI:119915

object_name: pleural disease


subject: CHEBI:119915

object_name: Malignant pleural effusion


subject: UNII:X150A3JK8R

subject_name: Aclimostat

object_name: type 2 diabetes mellitus


subject: UNII:X150A3JK8R

object_name: Overweight and obesity


subject: CHEBI:64212

subject_name: Exisulind

object_name: small intestine cancer


subject: CHEBI:64212

object_name: small intestine carcinoma


subject: CHEBI:64212

object_name: colorectal cancer


subject: CHEBI:64212

object_name: colorectal carcinoma


subject: CHEBI:64212

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:47499

subject_name: Imipramine

object_name: endogenous depression


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: pulmonary sarcoidosis


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: CHEBI:87631

subject_name: statin

object_name: intracerebral hemorrhage


subject: CHEBI:64073

object_name: cardiovascular disorder


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON


subject: CHEBI:5391

subject_name: Glucagon


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:71272

subject_name: Saxagliptin

object_name: type 1 diabetes mellitus 1


subject: CHEBI:71272

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C0597354

subject_name: Radiotracers

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:15251598

subject_name: Ammonium tetrathiomolybdate

object_name: lung cancer


subject: PUBCHEM.COMPOUND:15251598

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:15251598

object_name: lung carcinoma


subject: CHEBI:232403


subject: CHEBI:232403


subject: CHEBI:232403


subject: UNII:4V6I63LW1E


subject: UNII:4V6I63LW1E


subject: UNII:4V6I63LW1E


subject: CHEBI:31596

subject_name: Febuxostat

object_name: Diabetes


subject: CHEBI:31596

object_name: diabetes mellitus


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: AIDS


subject: CHEBI:43796

subject_name: (S)-lipoic acid

object_name: HIV infection


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Abnormality of the temporomandibular joint


subject: HMDB:HMDB0014612

subject_name: Tenoxicam


subject: PUBCHEM.COMPOUND:9815560

subject_name: Estreptoquinasa

object_name: Prosthetic Valve Thrombosis


subject: UNII:8X1OXL3SNU

subject_name: STREPTOKINASE


subject: UMLS:C0038418

subject_name: streptokinase


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: Advanced cancer


subject: UNII:333OX80X87

subject_name: Trafermin

object_name: Wound healed (finding)


subject: UMLS:C3692257

subject_name: Basic Fibroblast Growth Factor


subject: UMLS:C1522505

subject_name: Recombinant Fibroblast Growth Factor-2


subject: UMLS:C0380603

subject_name: Fibroblast Growth Factor 2


subject: CHEBI:229649

subject_name: Leniolisib

object_name: PIK3CD gene mutation


subject: CHEBI:176724

subject_name: Etiracetam

object_name: cerebral malaria


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: UMLS:C5417914

subject_name: ISAC BDC-1001

object_name: HER2 positive endometrial cancer


subject: UMLS:C5417914

object_name: HER2 positive colorectal cancer


subject: UMLS:C5417914

object_name: HER2 positive breast carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: acute myeloid leukemia with 11q23 abnormalities


subject: PUBCHEM.COMPOUND:1805

object_name: acute myeloid leukemia with t(9;11)(p22;q23)


subject: PUBCHEM.COMPOUND:1805

object_name: Leukemia Cutis


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:230493

subject_name: pinometostat

object_name: Refractory acute myeloid leukemia


subject: CHEBI:230493


subject: CHEBI:230493


subject: CHEBI:230493

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:230493


subject: UNII:8V9YR09EF3

subject_name: Pinometostat


subject: UNII:8V9YR09EF3


subject: UNII:8V9YR09EF3


subject: UNII:8V9YR09EF3


subject: UNII:8V9YR09EF3


subject: UMLS:C0540301

subject_name: C1 esterase inhibitor

object_name: Immunity, Innate


subject: UMLS:C0009500

subject_name: Complement C1 Inactivator Proteins


subject: UMLS:C0003209

subject_name: Anti-Inflammatory Agents

object_name: Rectal fistula


subject: UMLS:C0003209

object_name: hemorrhoid


subject: UMLS:C0003209

object_name: Hemorrhoids, CTCAE 3.0


subject: UMLS:C0003209

object_name: Hemorrhoids, CTCAE 5.0


subject: UMLS:C0003209

object_name: Anal fissure


subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: HSAN Type IV


subject: CHEBI:4672

subject_name: Docetaxel

object_name: carcinosarcoma of the corpus uteri


subject: CHEBI:4672

object_name: uterine carcinosarcoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: UMLS:C4287775

object_name: plasma cell myeloma


subject: CHEBI:27732

subject_name: Caffeine

object_name: Solid Neoplasm


subject: CHEBI:87738

subject_name: (S)-Warfarin


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:18067

subject_name: Phylloquinone


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: UMLS:C5554963

subject_name: Multi-kinase Inhbitor AIV001

object_name: Traumatic Wound


subject: CHEBI:94534

subject_name: olanzapine

object_name: Testicular Cancer by AJCC v6 and v7 Stage


subject: UNII:9J13XU96Z1

subject_name: Azenosertib

object_name: Locally Advanced Gastroesophageal Junction Adenocarcinoma


subject: UNII:9J13XU96Z1

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: UNII:9J13XU96Z1

object_name: Locally Advanced Gastric Carcinoma


subject: UNII:9J13XU96Z1

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: UNII:9J13XU96Z1

object_name: Metastatic Gastric Carcinoma


subject: UNII:9J13XU96Z1

object_name: Unresectable Gastric Carcinoma


subject: UNII:9J13XU96Z1

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UNII:9J13XU96Z1

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:9J13XU96Z1

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:9J13XU96Z1

object_name: Unresectable Malignant Solid Neoplasm


subject: UNII:9J13XU96Z1

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: UNII:9J13XU96Z1

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: UNII:9J13XU96Z1

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C5782830

subject_name: ROPivacaine 0.5% injectable solution

object_name: pain agnosia


subject: UMLS:C5782830

object_name: Pain insensitivity


subject: UMLS:C5782830

object_name: Obstruction


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356

object_name: Gabapentin adverse reaction


subject: CHEBI:64356

object_name: opioid abuse


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: eye inflammation


subject: CHEMBL.COMPOUND:CHEMBL2109533

subject_name: ORTICUMAB

object_name: psoriasis


subject: CHEMBL.COMPOUND:CHEMBL2109533

object_name: Cardiometabolic Syndrome


subject: CHEMBL.COMPOUND:CHEMBL2109533

object_name: abdominal obesity-metabolic syndrome


subject: CHEMBL.COMPOUND:CHEMBL2109533

object_name: coronary artery disorder


subject: CHEMBL.COMPOUND:CHEMBL2109533

object_name: coronary atherosclerosis


subject: CHEMBL.COMPOUND:CHEMBL2109533

object_name: Inflammation


subject: UMLS:C5238046

subject_name: Orticumab


subject: UMLS:C5238046


subject: UMLS:C5238046


subject: UMLS:C5238046


subject: UMLS:C5238046


subject: UMLS:C5238046


subject: UMLS:C1134588

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:14326905

object_name: metastatic malignant neoplasm in the brain


subject: PUBCHEM.COMPOUND:14326905

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:14326905

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:14326905

object_name: Malignant Solid Neoplasm


subject: UNII:3HX21A3SQF

subject_name: Ropidoxuridine


subject: UNII:3HX21A3SQF


subject: UNII:3HX21A3SQF


subject: UNII:3HX21A3SQF


subject: UMLS:C4048712

subject_name: factor IX complex

object_name: acquired hemophilia


subject: UMLS:C0700346

subject_name: Koate-DVI


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: UMLS:C0086135

subject_name: DDAVP


subject: CHEBI:2948

subject_name: Azathioprine


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:188197

object_name: Adult Meningioma


subject: CHEBI:188197

object_name: benign meningioma


subject: CHEBI:188197

object_name: familial meningioma


subject: CHEBI:188197

object_name: pediatric meningioma


subject: CHEBI:188197

object_name: meningioma


subject: CHEBI:188197

object_name: acoustic neuroma


subject: CHEBI:188197

object_name: neurofibromatosis


subject: CHEBI:188197

object_name: NF2-related schwannomatosis


subject: CHEBI:188197

object_name: vestibular schwannomatosis


subject: GTOPDB:9948

subject_name: naptumomab estafenatox

object_name: urothelial carcinoma


subject: GTOPDB:9948

object_name: transitional cell carcinoma


subject: UNII:93T929W6LC

subject_name: NAPTUMOMAB ESTAFENATOX


subject: UNII:93T929W6LC


subject: UMLS:C1328194


subject: UMLS:C1328194


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: CHEBI:2663

subject_name: Amiodarone

object_name: carcinoma of esophagus


subject: UNII:35F0Y2W16Q

subject_name: Felcisetrag

object_name: Enteral feeding intolerance


subject: UMLS:C3661040


subject: UMLS:C1449405

subject_name: Siccoral

object_name: chronic kidney disease


subject: UNII:49X2Q41T99

subject_name: PEGSITACIANINE

object_name: peritoneal carcinomatosis


subject: UNII:Y64GQ0KC0A

subject_name: Teprotumumab

object_name: Graves disease


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives

object_name: arteriosclerosis disorder


subject: UMLS:C3540032

object_name: atherosclerosis


subject: UMLS:C3540032

object_name: cardiovascular disorder


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: UMLS:C3714649


subject: UMLS:C3714649


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:4856

subject_name: Esmolol

object_name: Postoperative Pain, Chronic


subject: CHEBI:4856

object_name: Acute Pain


subject: CHEBI:4856

object_name: pain agnosia


subject: CHEBI:4856

object_name: Pain insensitivity


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: UMLS:C4301616

subject_name: fluoroestradiol (18F)

object_name: invasive lobular breast carcinoma


subject: UMLS:C5439626

subject_name: Fluoroestradiol f 18, diagnostic, 1 millicurie


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)


subject: CHEBI:90001

subject_name: cystathionine ketimine


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: type 2 diabetes mellitus


subject: CHEBI:30011

subject_name: L-glutamine residue


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: CHEBI:8665

object_name: primary dysautonomia


subject: CHEBI:8665

object_name: dysautonomia


subject: CHEBI:8665

object_name: autonomic nervous system disorder


subject: CHEBI:8665

object_name: Exercise intolerance


subject: CHEBI:8665

object_name: orthostatic hypotension


subject: UNII:98OYR854NY

subject_name: Trabedersen

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UNII:98OYR854NY

object_name: Non-small cell lung cancer recurrent


subject: UNII:98OYR854NY

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C5854667


subject: UMLS:C5854667


subject: UMLS:C5854667


subject: CHEBI:42797

subject_name: Gabapentin

object_name: urinary bladder carcinoma


subject: UMLS:C4053657

object_name: Myelodysplasia


subject: UMLS:C4053657

object_name: acute myeloid leukemia


subject: UMLS:C1135124

object_name: cancer


subject: UMLS:C1135124

object_name: neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4298176

subject_name: GARETOSMAB

object_name: myositis ossificans


subject: CHEMBL.COMPOUND:CHEMBL4298176

object_name: fibrodysplasia ossificans progressiva


subject: UMLS:C5418397

subject_name: Garetosmab


subject: UMLS:C5418397


subject: UMLS:C4530095

subject_name: varicella zoster virus glycoprotein E, recombinant

object_name: Varicella zoster


subject: UNII:S052TOI9BI

subject_name: Vestipitant

object_name: post operative nausea and vomiting


subject: UMLS:C2745432

subject_name: Meditoxin

object_name: Spasticity


subject: CHEBI:3561

subject_name: Cetirizine

object_name: Acute urticaria


subject: UMLS:C5222425

subject_name: Diphenhydramine Hydrochloride Liquid Injection


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:231614

subject_name: Nivolumab

object_name: follicular lymphoma


subject: UMLS:C2346820


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: DRUGBANK:DB14275

subject_name: Indian frankincense

object_name: Childhood Breast Carcinoma


subject: DRUGBANK:DB14275

object_name: breast carcinoma


subject: DRUGBANK:DB14275

object_name: breast cancer


subject: UMLS:C5971076

subject_name: boswellia (chemical)


subject: UMLS:C5971076


subject: UMLS:C5971076


subject: CHEBI:27363

subject_name: Zinc

object_name: periodontitis, chronic, adult


subject: CHEBI:27363

object_name: chronic periodontitis


subject: CHEBI:3757

subject_name: Clonidine

object_name: Leg length inequality in children


subject: CHEBI:3757

object_name: Foot osteomyelitis


subject: CHEBI:3757

object_name: Congenital Hand and Foot Deformity


subject: CHEBI:3757

object_name: Talipes Calcaneus


subject: CHEBI:3757

object_name: clubfoot


subject: CHEBI:3757

object_name: Dorsiflexion deformity of foot


subject: CHEBI:3757

object_name: Congenital valgus deformity of foot


subject: CHEBI:3757

object_name: Congenital Hand Deformities


subject: CHEBI:3757

object_name: Osteomyelitis of hindfoot


subject: CHEBI:3757

object_name: Congenital deformity of knee joint


subject: CHEBI:3757

object_name: Osteomyelitis of midfoot


subject: CHEBI:3757

object_name: capsulitis of metatarsophalangeal joint


subject: CHEBI:3757

object_name: Short thumb


subject: CHEBI:3757

object_name: exostosis, Dupuytren subungual


subject: CHEBI:3757

object_name: Pes valgus


subject: CHEBI:3757

object_name: Hand polydactyly


subject: CHEBI:3757

object_name: Toe joint deformity


subject: CHEBI:3757

object_name: tarsal coalition


subject: CHEBI:3757

object_name: Deviation of finger


subject: CHEBI:3757

object_name: Foot polydactyly


subject: CHEBI:3757

object_name: synpolydactyly


subject: CHEBI:3757

object_name: Acquired trigger finger


subject: CHEBI:3757

object_name: trigger thumb


subject: CHEBI:3757

object_name: Absent thumb


subject: CHEBI:3757

object_name: Toe deformity


subject: CHEBI:3757

object_name: flatfoot


subject: CHEBI:3757

object_name: non-syndromic polydactyly


subject: CHEBI:3757

object_name: polydactyly


subject: CHEBI:3757

object_name: hollow foot


subject: CHEBI:3757

object_name: Syndactyly


subject: CHEBI:3757

object_name: x-ray of toe: syndactyly


subject: CHEBI:3757

object_name: Acquired clubfoot


subject: MESH:D013607

subject_name: Tablets

object_name: bipolar disorder


subject: MESH:D013607

object_name: bipolar depression


subject: DRUGBANK:DB16503

object_name: influenza


subject: CHEBI:149504

object_name: Ischemic stroke


subject: CHEBI:6541

subject_name: Losartan


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Polyp of nasal sinus


subject: UMLS:C5203530

object_name: Sinus Cancer


subject: UMLS:C5203530

object_name: chronic rhinosinusitis


subject: UMLS:C5203530

object_name: isolated encephalocele


subject: UMLS:C5203530

object_name: cephalocele


subject: UMLS:C5203530

object_name: Encephalocele


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:94518


subject: CHEBI:94518